SLC7A11 and cancer: Taken together, our study revealed the novel significance of NRF2 activation and GSH synthesis in cancer treatment, and pharmacological targeting of NRF2‐SLC7A11 signaling pathway could be considered as promising avenue for the treatment of drug‐resistant HCC in clinical settings, offering a novel insight into the precise cancer treatment via regulating disulfidptosis.